IM Cannabis

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20. » Mehr auf investorplace.com

In the ever-evolving landscape of the US cannabis industry, marijuana stocks have been lighting up the market, with some experiencing triple-digit gains in the last month. Investors are keenly watching these volatile but potentially lucrative investments. The surge in interest comes as the industry sees an upward trajectory, buoyed by increasing legalization efforts and a growing acceptance of cannabis for both medical and recreational use. With the sector's projected expansion, savvy investors are diving into the market. However, it's crucial to approach these opportunities with a solid strategy, employing technical analysis and proper risk management to navigate the inherent risks. » Mehr auf marijuanastocks.com

The partnership's core objective is to grant IM Cannabis' (IMCC) subsidiary, Adjupharm GmbH, exclusive rights to introduce Avant's BLK MKT cannabis brand in Germany's medical cannabis market. » Mehr auf zacks.com